277 (Januvia 100 mg)
Generic Name: sitagliptin
Pill imprint 277 has been identified as Januvia 100 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 100 mg
- 10.00 mm
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Merck & Company Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
ferric oxide red
sodium stearyl fumarate
ferric oxide yellow
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|54569-5925||A-S Medication Solutions, LLC (repackager)|
|54868-5840||Physicians Total Care Inc (repackager)|
|35356-0103||Lake Erie Medical and Surgical Supply (repackager)|
|68258-5990||Dispensing Solutions Inc. (repackager)|
More about Januvia (sitagliptin)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 59 Reviews – Add your own review/rating
- Drug class: dipeptidyl peptidase 4 inhibitors
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.